{
    "nct_id": "NCT04200911",
    "title": "Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway (CARPE DIEM)",
    "status": "COMPLETED",
    "last_update_time": "2025-01-03",
    "description_brief": "Evaluation of central nervous system penetration of orally administered Rapamune (RAPA) in older adults with Mild Cognitive Impairment (MCI) or early Alzheimer's disease (AD) and investigate associated safety, tolerability, target engagement, cognition, and functional status as initial proof-of-concept study",
    "description_detailed": "This study is an open-label pilot study of orally administered RAPA to measure its target engagement in Cerebrospinal Fluid (CSF) and blood, and to establish the feasibility and safety of RAPA treatment in older adults with MCI and early stage AD as initial proof-of-concept for a larger Phase 2 clinical trial.",
    "phase": [
        "EARLY_PHASE1"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "recruitmentDetails": "Subjects that were enrolled and passed eligibility screening and went on to randomization.",
            "groups": [
                {
                    "id": "FG000",
                    "title": "RAPA Intervention",
                    "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "10"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "10"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "RAPA Intervention",
                    "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "10"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "74",
                                            "spread": "4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Diagnosis",
                    "description": "Clinical diagnosis of mild cognitive impairment or early-stage Alzheimer's disease by a qualified physician",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Mild cognitive impairment",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        }
                                    ]
                                },
                                {
                                    "title": "Early-stage dementia",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Blood Brain Barrier Penetration of RAPA",
                    "description": "Lumbar punctures will be performed at baseline and after the final RAPA dose, to assess CSF levels of the drug. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "populationDescription": "HPLC/MS/MS",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ng/ml",
                    "timeFrame": "Change from Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0",
                                            "spread": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Adverse Events",
                    "description": "Number of adverse events experienced across all 10 subjects after they were enrolled and randomized to treatment, regardless of relatedness to intervention.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "Events",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Vitals From Baseline to 8 Weeks",
                    "description": "Evaluation of vitals. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "populationDescription": "paired samples t-test comparing pre to post-treatment blood pressure.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "mmHg",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "systolic blood pressure",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "10.45",
                                            "spread": "7.82"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "diastolic blood pressure",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.7",
                                            "spread": "5.87"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Percentage of Study Drug Pills Taken",
                    "description": "Average percentage of study drug pills taken across all 10 subjects after they were enrolled and randomized to treatment. The percentage of study drug pills taken was evaluated by having participants return any leftover study drug pills at each visit during the active treatment period.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "percentage of study drug pills taken",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "92",
                                            "spread": "5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in CSF AD Biomarkers From Baseline to 8 Weeks",
                    "description": "Evaluation of CSF AD biomarkers. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "populationDescription": "paired samples t-test comparing pre to post-treatment CSF ADRD biomarker levels",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ng/ml",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "CSF ptau-181",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.64",
                                            "spread": "2.72"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF abeta 40",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "615.57",
                                            "spread": "1210.06"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF Abeta42",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "21.52",
                                            "spread": "62.12"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF GFAP",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6262.21",
                                            "spread": "4928.96"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CSF NFL",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "367.18",
                                            "spread": "310.71"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Plasma AD Biomarkers From Baseline to 8 Weeks",
                    "description": "Evaluation of plasma AD biomarkers. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "populationDescription": "paired samples t-test comparing pre to post-treatment plasma ADRD biomarker levels",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ng/ml",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "plasma ptau-181",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.22",
                                            "spread": "0.47"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "plasma abeta 40",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-8.86",
                                            "spread": "12.28"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma Abeta42",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.67",
                                            "spread": "0.69"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma GFAP",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-27.70",
                                            "spread": "64.78"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Plasma NFL",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.84",
                                            "spread": "4.64"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in CSF Inflammatory Markers From Baseline to 8 Weeks",
                    "description": "Evaluation of CSF inflammatory markers. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "populationDescription": "paired samples t-test comparing pre to post-treatment CSF inflammatory values.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg/ml",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "IL-10",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.02",
                                            "spread": "0.02"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-6",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.02",
                                            "spread": "0.25"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-8",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "5.76",
                                            "spread": "9.10"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "TNF-\u03b1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.03",
                                            "spread": "0.07"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-12",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.35",
                                            "spread": "0.53"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-15",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.29",
                                            "spread": "0.28"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-16",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.63",
                                            "spread": "3.40"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-17a",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.03",
                                            "spread": "0.09"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-1a",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.15",
                                            "spread": "0.33"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-5",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.07",
                                            "spread": "0.07"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-7",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.004",
                                            "spread": "0.10"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "VEGF-A",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.95",
                                            "spread": "2.37"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "VEGF-C",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "266.60",
                                            "spread": "575.93"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "VEGF-D",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "109.64",
                                            "spread": "117.23"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Eotaxin",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-5.05",
                                            "spread": "32.40"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Eotaxin-3",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.20",
                                            "spread": "2.20"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IP-10",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-12.93",
                                            "spread": "143.87"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "MCP-1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-22.56",
                                            "spread": "78.00"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "MIP1-\u03b1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.83",
                                            "spread": "2.90"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "sFLT-1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "41.18",
                                            "spread": "253.61"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "PIGF",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.84",
                                            "spread": "40.66"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "bFGF",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.69",
                                            "spread": "20.85"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "sVCAM1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "21202.57",
                                            "spread": "24439.62"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "sICAM1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6701.21",
                                            "spread": "13402.98"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SAA",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-73762.91",
                                            "spread": "375497.74"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CRP",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-98910.45",
                                            "spread": "27540.81"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IFN-\u03b3",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.14",
                                            "spread": "0.17"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Plasma Inflammatory Markers From Baseline to 8 Weeks",
                    "description": "Evaluation of plasma inflammatory markers. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "populationDescription": "paired samples t-test comparing pre to post-treatment plasma inflammatory biomarkers.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg/ml",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "IL-10",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.18",
                                            "spread": "0.53"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-6",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.29",
                                            "spread": "0.54"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-8",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.16",
                                            "spread": "1.57"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "TNF-\u03b1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.06",
                                            "spread": "0.44"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-12",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-16.56",
                                            "spread": "38.52"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-15",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.12",
                                            "spread": "0.31"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-16",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "16.18",
                                            "spread": "42.70"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-17a",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.36",
                                            "spread": "1.68"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-1a",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.20",
                                            "spread": "0.36"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-5",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.34",
                                            "spread": "0.46"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IL-7",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.14",
                                            "spread": "1.63"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "VEGF-A",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.05",
                                            "spread": "7.98"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "VEGF-C",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2000.38",
                                            "spread": "6648.40"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "VEGF-D",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3741.02",
                                            "spread": "3124.38"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Eotaxin",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "22.07",
                                            "spread": "36.04"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Eotaxin-3",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-3.60",
                                            "spread": "6.19"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IP-10",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "18.26",
                                            "spread": "80.08"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "MCP-1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-4.80",
                                            "spread": "10.74"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "MIP1-\u03b1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.83",
                                            "spread": "3.64"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "sFLT-1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "258.88",
                                            "spread": "237.44"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "PIGF",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20.81",
                                            "spread": "11.81"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "bFGF",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-143.67",
                                            "spread": "174.71"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "sVCAM1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "97456.61",
                                            "spread": "1400309.82"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "sICAM1",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "91844.33",
                                            "spread": "1329185.57"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SAA",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "190090000",
                                            "spread": "936172849.0"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "CRP",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "36165816.2",
                                            "spread": "111516450.7"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "IFN-\u03b3",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4.37",
                                            "spread": "1.91"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in White Blood Cell and Platelet Counts From Baseline to 8 Weeks",
                    "description": "Evaluation of safety labs - white blood cell and platelet counts. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "populationDescription": "paired samples t-test comparing pre to post-treatment safety laboratory values.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "x10^3 cells/\u03bcL",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "White Blood Cell Count",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.42",
                                            "spread": "1.92"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Immature Granulocytes",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.21",
                                            "spread": "1.19"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Eosinophils",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.10",
                                            "spread": "2.5"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Basophils",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.19",
                                            "spread": "0.40"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Platelets",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20.60",
                                            "spread": "35.19"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Red Blood Cell Count",
                    "description": "Evaluation of safety labs - red blood cell counts. Change in red blood cell count calculated as value at 8 weeks minus the value at baseline.",
                    "populationDescription": "paired sample's t-test comparing pre to post-treatment safety laboratory values",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "x10^6 cells/\u03bcL",
                    "timeFrame": "Baseline to 8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.01",
                                            "spread": "0.27"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Mean Corpuscular Volume",
                    "description": "Evaluation of safety labs - Change in Mean Corpuscular volume. Change is calculated as value at 8 weeks minus the value at baseline",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "fL",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.70",
                                            "spread": "2.16"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Mean Corpuscular Hemoglobin",
                    "description": "safety labs - Mean Corpuscular Hemoglobin. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg",
                    "timeFrame": "8-weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.81",
                                            "spread": "0.69"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Metabolic Parameters (g/dl)",
                    "description": "Evaluation of safety labs - metabolic parameters. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "g/dl",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Hemoglobin",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.27",
                                            "spread": "0.57"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Protein",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.77",
                                            "spread": "5.85"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Albumin",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.13",
                                            "spread": "0.19"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Mean Corpuscular Hemoglobin Concentration",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.08",
                                            "spread": "0.85"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Hematocrit",
                    "description": "Evaluation of of safety labs - hematocrit. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "percentage of red blood cells",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.86",
                                            "spread": "2.09"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Monocytes",
                    "description": "Evaluation of of safety labs - monocytes. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "percentage of white blood cell count",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.19",
                                            "spread": "4.08"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Red Cell Distribution Width",
                    "description": "Evaluation of of safety labs - Red cell distribution width. Change is calculated as value at 8 weeks minus the value at baseline. The value reported is % of red blood cell size and volume variability.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Percentage",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.65",
                                            "spread": "0.24"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Hemoglobin A1c",
                    "description": "Evaluation of of safety labs - hemoglobin A1c. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "% of hemoglobin covered w/ glucose",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.17",
                                            "spread": "0.22"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Metabolic and Lipid Parameters (mg/dl)",
                    "description": "Evaluation of safety labs - metabolic and lipid parameters. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "mg/dl",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "glucose",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.70",
                                            "spread": "6.67"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "blood urea nitrogen",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.80",
                                            "spread": "4.13"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Creatinine",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.001",
                                            "spread": "0.09"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Bilirubin",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.09",
                                            "spread": "0.34"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Cholesterol",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.30",
                                            "spread": "26.08"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "High-Density Lipoprotein Cholesterol",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2.90",
                                            "spread": "7.22"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Low-Density Lipoprotein Cholesterol",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-2.70",
                                            "spread": "20.38"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Very Low-Density Lipoprotein Cholesterol",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.50",
                                            "spread": "4.25"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Sodium and Potassium (mmol/L)",
                    "description": "Evaluation of safety labs - sodium and potassium. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "mmol/L",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Sodium",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-5.40",
                                            "spread": "18.90"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Potassium",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.19",
                                            "spread": "0.44"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Safety Labs - Change in Liver Panel (iU/L)",
                    "description": "Evaluation of safety labs - liver panel. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "IU/L",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Aspartate Aminotransferase",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.00",
                                            "spread": "4.06"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Alanine Transaminase",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.001",
                                            "spread": "6.20"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Alkaline Phosphatase",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4.10",
                                            "spread": "10.90"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change in Montreal Cognitive Assessment (MoCA)",
                    "description": "The Montreal Cognitive Assessment (MoCA) assesses global cognition with scores ranging from 0 to 30 points. Higher scores indicate better performance.Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.30",
                                            "spread": "2.45"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Clinical Rating Scale Global Score",
                    "description": "The Clinical Rating Scale Global Score assesses cognition and daily functioning with scores ranging from 0 to 3 points. Higher scores indicate worse cognition and/or functional status.Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.15",
                                            "spread": "0.16"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Clinical Rating Scale Sum of Boxes Score",
                    "description": "The Clinical Rating Scale Sum of Boxes assesses cognition and daily functioning with scores ranging from 0 to 18 points. Higher scores indicate worse cognition and/or functional status.Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.55",
                                            "spread": "0.86"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Hopkins Verbal Learning Test - Revised Immediate Recall",
                    "description": "The Hopkins Verbal Learning Test - Revised Immediate Recall assesses verbal list learning with scores ranging from 0 to 36 points. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.40",
                                            "spread": "3.37"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Hopkins Verbal Learning Test - Revised Delayed Recall",
                    "description": "The Hopkins Verbal Learning Test - Revised Delayed Recall assesses verbal list learning with scores ranging from 0 to 12 points. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.00",
                                            "spread": "2.54"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Craft Story Immediate Recall Verbatim",
                    "description": "The Craft Story Immediate Recall Verbatim assesses verbal narrative learning with scores ranging from 0 to 44 points. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.20",
                                            "spread": "4.29"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Craft Story Delayed Recall Verbatim",
                    "description": "The Craft Story Delayed Recall Verbatim assesses verbal memory recall with scores ranging from 0 to 44 points. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.40",
                                            "spread": "2.95"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Benson Figure Copy",
                    "description": "The Benson Figure Copy assesses visuoconstructional skills with scores ranging from 0 to 17points. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.70",
                                            "spread": "1.83"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Benson Figure Delayed Recall",
                    "description": "The Benson Figure Delayed Recall assesses visual memory with scores ranging from 0 to 17 points. Higher scores indicate better performance.Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.80",
                                            "spread": "2.04"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Number Span Forward",
                    "description": "The Number Span Forward test assesses basic attention with scores ranging from 0 to 16 points. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.20",
                                            "spread": "1.62"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Number Span Backward",
                    "description": "The Number Span Backward test assesses working memory with scores ranging from 0 to 14 points. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.60",
                                            "spread": "0.84"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Trail Making Test Part A, Time to Completion",
                    "description": "The Trail Making Test Part A, time to completion assesses psychomotor speed and visual scanning with scores ranging from 1 to 150 seconds. Higher scores indicate worse performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "seconds to complete",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3.09",
                                            "spread": "3.15"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change Trail Making Test Part B, Time to Completion",
                    "description": "The Trail Making Test Part B, time to completion assesses attentional shifting with scores ranging from 1 to 300 seconds. Higher scores indicate worse performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "seconds to complete",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.69",
                                            "spread": "14.97"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on Phonemic Fluency",
                    "description": "The Phonemic fluency test assesses speeded word generation to a phonemic cue. Scores begin at 0 with no upper limit. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.80",
                                            "spread": "3.71"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on Semantic Fluency",
                    "description": "The Semantic fluency test assesses speeded word generation to a semantic cue. Scores begin at 0 with no upper limit. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.10",
                                            "spread": "4.18"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Multilingual Naming Test",
                    "description": "The Multilingual Naming Test assesses confrontation naming. Scores range from 0 to 32 and higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.50",
                                            "spread": "4.67"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Hayling, Total Errors",
                    "description": "The Hayling assesses response inhibition errors. Scores range from 0 to 30 and higher scores indicate worse performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.001",
                                            "spread": "0.78"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on Grip Strength, Dominant Hand",
                    "description": "The grip strength, dominant hand assesses grip strength in kilograms. Values begin at 0 with no upper limit. Higher scores indicate better performance Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "kilograms",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.30",
                                            "spread": "2.10"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on Grip Strength, Non-dominant Hand",
                    "description": "The grip strength, non-dominant hand assesses grip strength in kilograms. Values begin at 0 with no upper limit. Higher scores indicate better performance. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "kilograms",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.25",
                                            "spread": "3.30"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Geriatric Depression Scale 15-item",
                    "description": "The Geriatric Depression Scale 15-item assesses depressive symptomatology. Scores range from 0 to 15 and higher scores indicate worse outcomes. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.10",
                                            "spread": "1.73"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Functional Activities Questionnaire",
                    "description": "The Functional Activities Questionnaire assesses functional status for independent activities of daily living. Scores range from 0 to 30 and higher scores indicate worse outcomes. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.10",
                                            "spread": "4.36"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Cognition/Functional Status - Change on the Neuropsychiatric Inventory Questionnaire",
                    "description": "The Neuropsychiatric Inventory Questionnaire assesses neuropsychiatric symptoms. Scores range from 0 to 12 and higher scores indicate worse outcomes. Change is calculated as value at 8 weeks minus the value at baseline.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "8 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "RAPA Intervention",
                            "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.70",
                                            "spread": "2.83"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "8 weeks",
            "description": "All adverse events that occurred after enrollment and randomization are reported, whether considered not related to or possible related to intervention.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "RAPA Intervention",
                    "description": "Sirolimus 1mg orally once a day for 8 weeks\n\nRapamune: Sirolimus 1mg capsules",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 10,
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 10,
                    "otherNumAffected": 10,
                    "otherNumAtRisk": 10
                }
            ],
            "seriousEvents": [
                {
                    "term": "Altered Mental Status",
                    "organSystem": "Nervous system disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Unrelated to study intervention, possible TIA",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Intermittent Rash",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild and unlikely to be related to intervention",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Moderate and not related to intervention",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Urinary retention",
                    "organSystem": "Renal and urinary disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild and unlikely related to intervention",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Hyperkalemia",
                    "organSystem": "Blood and lymphatic system disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild and unlikely to be related to intervention",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Upper respiratory infection",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild and unlikely to be related to intervention for one subject, possible for the other",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Skin infection",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Not related to intervention (kitten scratches)",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Leg edema",
                    "organSystem": "Blood and lymphatic system disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild for one subject, moderate for the other and unlikely to be related to intervention",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Emesis",
                    "organSystem": "Gastrointestinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild, unlikely to have been related to study intervention",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Cough",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild and not likely to be related to intervention",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Diarrhea",
                    "organSystem": "Gastrointestinal disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild, one subject was possibly related, the other was not",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Urinary incontinence",
                    "organSystem": "Renal and urinary disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild and unlikely related",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Urinary urgency",
                    "organSystem": "Renal and urinary disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild and unlikely related",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "General disorders",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "notes": "Mild and unlikely related",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 10
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": true
            },
            "pointOfContact": {
                "title": "Mitzi Gonzales, PhD",
                "organization": "UT Health San Antonio",
                "email": "Gonzalesm20@uthscsa.edu",
                "phone": "210-450-9047"
            }
        }
    },
    "target_category": "disease-targeted small molecule",
    "drug": [
        "Rapamune (sirolimus / rapamycin) \u2014 oral mTOR inhibitor (small molecule)."
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The trial tests orally administered Rapamune (brand name for sirolimus / rapamycin), an mTOR inhibitor, in people with MCI or early AD to evaluate CNS penetration, safety/tolerability, target engagement and cognitive/functional outcomes \u2014 indicating an intervention that targets a disease-related pathway (mTOR/autophagy) rather than a symptomatic-only cognitive enhancer. \ue200cite\ue202turn0search6\ue202turn0search2\ue202turn1search7\ue201",
        "Act (extraction): Key details from the trial description \u2014 Title: CARPE DIEM (Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway); population: older adults with MCI or early AD; intervention: orally administered Rapamune (sirolimus); primary experimental aim: assess CNS (CSF) penetration and target engagement plus safety, tolerability, and preliminary cognitive/functional effects. \ue200cite\ue202turn0search6\ue201",
        "Act (drug information): Rapamune is the marketed formulation of sirolimus (rapamycin), an orally administered small-molecule inhibitor that binds FKBP12 and inhibits the mechanistic target of rapamycin (mTOR). It is an approved drug for immunosuppression and other indications (prescribing information). \ue200cite\ue202turn0search2\ue202turn0search8\ue201",
        "Reflect (classification): Sirolimus/rapamycin is a small-molecule mTOR inhibitor that targets a molecular pathway (mTOR) implicated in AD pathophysiology (autophagy, protein clearance, neuroinflammation, BBB integrity). Because it is a small molecule acting on disease-relevant biology (not a biologic like an antibody, and not solely a symptomatic cognitive enhancer or neuropsychiatric treatment), the correct category is: disease-targeted small molecule. \ue200cite\ue202turn0search7\ue202turn1search4\ue202turn1search2\ue201",
        "Web-search evidence (sources used): 1) Trial description / CARPE DIEM study page (trial purpose, population, endpoints). \ue200cite\ue202turn0search6\ue201 2) Rapamune (sirolimus) prescribing/product information showing active ingredient and oral formulation. \ue200cite\ue202turn0search2\ue201 3) Mechanism-of-action summary (sirolimus binds FKBP12 and inhibits mTOR). \ue200cite\ue202turn0search8\ue201 4) Reviews and studies linking mTOR/rapamycin to AD-related biology and cognitive effects in preclinical models. \ue200cite\ue202turn1search7\ue202turn1search3\ue201 5) Drug identity/synonyms confirming sirolimus = rapamycin/Rapamune. \ue200cite\ue202turn0search7\ue201"
    ],
    "agent_type": "I) Proteostasis/Proteinopathies",
    "explanation_agent": [
        "Reason: The trial tests oral sirolimus/rapamycin (Rapamune), a small-molecule inhibitor of mTOR that is being used here to modulate autophagy/protein clearance and related disease pathways in people with MCI/early AD \u2014 this targets cellular proteostasis mechanisms implicated in Alzheimer disease. \ue200cite\ue202turn0search4\ue202turn0search7\ue201",
        "Act: Extracted details \u2014 Trial CARPE DIEM (NCT04200911) evaluates Rapamune (sirolimus) oral dosing to assess CNS penetration, target engagement, safety/tolerability and preliminary cognitive/biomarker effects in older adults with MCI/early AD (open\u2011label pilot). The drug\u2019s mechanism is FKBP12 binding and inhibition of mTOR, leading to increased autophagy/proteostasis effects investigated for AD. \ue200cite\ue202turn0search0\ue202turn0search2\ue202turn0search4\ue201",
        "Reflect: Mapping to CADRO \u2014 mTOR inhibition in this trial is intended to modify autophagy/protein clearance and other disease-related processes (not simply symptomatic neurotransmitter modulation). That aligns best with CADRO category I) Proteostasis/Proteinopathies rather than symptomatic or purely metabolic categories. Preclinical and review literature supports rapamycin\u2019s effects on autophagy, amyloid/tau-related pathology and cognition in models, consistent with a proteostasis-directed intervention. \ue200cite\ue202turn0search9\ue202turn0search10\ue202turn0search7\ue201",
        "Web-search evidence (selected sources used):",
        "- CARPE DIEM (NCT04200911) trial record \u2014 study purpose and endpoints (CSF penetration, target engagement, safety, cognition). \ue200cite\ue202turn0search0\ue201",
        "- Trial description / institutional trial page (Biggs Institute) \u2014 study aims and pre/post assessments. \ue200cite\ue202turn0search1\ue201",
        "- Rapamune (sirolimus) prescribing/FDA product information \u2014 mechanism: sirolimus:FKBP12 complex inhibits mTOR. \ue200cite\ue202turn0search4\ue201",
        "- Reviews and hypothesis papers on rapamycin/mTOR in Alzheimer disease (mechanistic rationale and preclinical evidence). \ue200cite\ue202turn0search7\ue202turn0search9\ue201",
        "Final classification (Output): I) Proteostasis/Proteinopathies \u2014 Rationale: Sirolimus (rapamycin) is being used to inhibit mTOR to modulate autophagy/protein clearance mechanisms implicated in AD, which fits CADRO category I. \ue200cite\ue202turn0search4\ue202turn0search7\ue201"
    ]
}